Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: post hoc analysis of the EOS individual participant data
Background: The effects of intravenous alteplase in patients with prior antiplatelet therapy (APT) remain controversial. We aimed to assess the efficacy and safety of imaging-based intravenous alteplase in patients with unknown onset stroke with prior APT. - Methods: Data from randomized controlled...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 7, 2025
|
| In: |
International journal of stroke
Year: 2025, Jahrgang: 20, Heft: 6, Pages: 679-686 |
| ISSN: | 1747-4949 |
| DOI: | 10.1177/17474930251322034 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1177/17474930251322034
|
| Verfasserangaben: | Yuma Shiomi, Kaori Miwa, Märit Jensen, Manabu Inoue, Sohei Yoshimura, Naruhiko Kamogawa, Mayumi Fukuda-Doi, Henry Ma, Peter Ringleb, Ona Wu, Lee H Schwamm, Stephen M Davis, Geoffrey A Donnan, Christian Gerloff, Jin Nakahara, Kazunori Toyoda, Götz Thomalla and Masatoshi Koga, on behalf of Evaluation of Unknown Onset Stroke Thrombolysis trials (EOS) Investigators |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 193225725X | ||
| 003 | DE-627 | ||
| 005 | 20250801110603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250801s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/17474930251322034 |2 doi | |
| 035 | |a (DE-627)193225725X | ||
| 035 | |a (DE-599)KXP193225725X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Shiomi, Yuma |e VerfasserIn |0 (DE-588)1372935312 |0 (DE-627)1932257780 |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy |b post hoc analysis of the EOS individual participant data |c Yuma Shiomi, Kaori Miwa, Märit Jensen, Manabu Inoue, Sohei Yoshimura, Naruhiko Kamogawa, Mayumi Fukuda-Doi, Henry Ma, Peter Ringleb, Ona Wu, Lee H Schwamm, Stephen M Davis, Geoffrey A Donnan, Christian Gerloff, Jin Nakahara, Kazunori Toyoda, Götz Thomalla and Masatoshi Koga, on behalf of Evaluation of Unknown Onset Stroke Thrombolysis trials (EOS) Investigators |
| 264 | 1 | |c February 7, 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.08.2025 | ||
| 520 | |a Background: The effects of intravenous alteplase in patients with prior antiplatelet therapy (APT) remain controversial. We aimed to assess the efficacy and safety of imaging-based intravenous alteplase in patients with unknown onset stroke with prior APT. - Methods: Data from randomized controlled trials comparing alteplase with placebo/standard care in patients with unknown onset acute ischemic stroke from the Evaluation of Unknown Onset Stroke Thrombolysis (EOS) individual patient data meta-analysis collaboration were analyzed. Favorable outcome was defined as a modified Rankin Scale score of 0-1 at 90 days post-stroke. Safety outcomes included symptomatic intracranial hemorrhage (sICH) at 22-36 h and 90-day mortality. - Results: Overall, 780 patients had available baseline data on prior APT. Compared with the no prior APT group (n = 523), the prior APT group (n = 257) was older (72 vs. 66 years) and had a higher prevalence of vascular risk factors. There was no interaction between prior APT and treatment effects of alteplase (p for interaction = 0.23). In the prior APT patients, 55/125 (45%) patients in the alteplase group and 39/132 (30%) patients in the control group had a favorable outcome (adjusted odds ratio [aOR], 2.07 [95% confidence interval, 1.18-3.64]). The rates of sICH and mortality in the alteplase and control groups were 5.6% and 0.8% (aOR, 7.78 [0.94-63.37]) and 6.5% and 6.1% (aOR, 1.12 [0.38-3.36]), respectively. In the no prior APT patients, 136 patients (50%) in the alteplase group and 112 patients (45%) in the control group had a favorable outcome (aOR, 1.39 [0.94-2.05]). Safety outcomes were not significantly different between the groups (sICH: 3 [1.1%] vs. 1 [0.4%]; mortality: 13 [4.9%] vs. 3 [1.2%]). - Conclusions: Alteplase has consistent efficacy regardless of prior APT in patients with unknown onset stroke. In addition, prior APT does not significantly increase the risk of sICH or mortality. | ||
| 700 | 1 | |a Miwa, Kaori |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jensen, Märit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Inoue, Manabu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yoshimura, Sohei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kamogawa, Naruhiko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fukuda-Doi, Mayumi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ma, Henry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ringleb, Peter A. |e VerfasserIn |0 (DE-588)1032676175 |0 (DE-627)73863364X |0 (DE-576)172917743 |4 aut | |
| 700 | 1 | |a Wu, Ona |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwamm, Lee H |e VerfasserIn |4 aut | |
| 700 | 1 | |a Davis, Stephen M |e VerfasserIn |4 aut | |
| 700 | 1 | |a Donnan, Geoffrey A |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gerloff, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nakahara, Jin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Toyoda, Kazunori |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomalla, Götz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koga, Masatoshi |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of stroke |d London : Sage, 2005 |g 20(2025), 6, Seite 679-686 |h Online-Ressource |w (DE-627)503720291 |w (DE-600)2211666-7 |w (DE-576)306832739 |x 1747-4949 |7 nnas |a Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy post hoc analysis of the EOS individual participant data |
| 773 | 1 | 8 | |g volume:20 |g year:2025 |g number:6 |g pages:679-686 |g extent:8 |a Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy post hoc analysis of the EOS individual participant data |
| 856 | 4 | 0 | |u https://doi.org/10.1177/17474930251322034 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250801 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1032676175 |a Ringleb, Peter A. |m 1032676175:Ringleb, Peter A. |d 910000 |d 911100 |e 910000PR1032676175 |e 911100PR1032676175 |k 0/910000/ |k 1/910000/911100/ |p 9 | ||
| 999 | |a KXP-PPN193225725X |e 4751964186 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"20(2025), 6, Seite 679-686","extent":"8","volume":"20","pages":"679-686","year":"2025","issue":"6"},"title":[{"title":"International journal of stroke","subtitle":"official journal of the World Stroke Organization","title_sort":"International journal of stroke"}],"titleAlt":[{"title":"official journal of the International Stroke Society"}],"id":{"eki":["503720291"],"zdb":["2211666-7"],"issn":["1747-4949"],"doi":["10.1111/(ISSN)1747-4949"]},"recId":"503720291","pubHistory":["Volume 1, issue 1 (February 2006)-"],"note":["Gesehen am 10.02.2021"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy post hoc analysis of the EOS individual participant dataInternational journal of stroke","language":["eng"],"origin":[{"publisherPlace":"London ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedDisp":"21 November 2005-","publisher":"Sage ; Blackwell ; Wiley-Blackwell"}]}],"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}],"note":["Gesehen am 01.08.2025"],"language":["eng"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"February 7, 2025"}],"person":[{"family":"Shiomi","roleDisplay":"VerfasserIn","given":"Yuma","display":"Shiomi, Yuma","role":"aut"},{"role":"aut","display":"Miwa, Kaori","roleDisplay":"VerfasserIn","given":"Kaori","family":"Miwa"},{"family":"Jensen","roleDisplay":"VerfasserIn","given":"Märit","display":"Jensen, Märit","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Inoue, Manabu","given":"Manabu","family":"Inoue","role":"aut"},{"role":"aut","family":"Yoshimura","roleDisplay":"VerfasserIn","display":"Yoshimura, Sohei","given":"Sohei"},{"family":"Kamogawa","roleDisplay":"VerfasserIn","display":"Kamogawa, Naruhiko","given":"Naruhiko","role":"aut"},{"display":"Fukuda-Doi, Mayumi","roleDisplay":"VerfasserIn","given":"Mayumi","family":"Fukuda-Doi","role":"aut"},{"given":"Henry","roleDisplay":"VerfasserIn","display":"Ma, Henry","family":"Ma","role":"aut"},{"role":"aut","family":"Ringleb","roleDisplay":"VerfasserIn","display":"Ringleb, Peter A.","given":"Peter A."},{"role":"aut","family":"Wu","roleDisplay":"VerfasserIn","display":"Wu, Ona","given":"Ona"},{"family":"Schwamm","roleDisplay":"VerfasserIn","given":"Lee H","display":"Schwamm, Lee H","role":"aut"},{"role":"aut","family":"Davis","given":"Stephen M","roleDisplay":"VerfasserIn","display":"Davis, Stephen M"},{"family":"Donnan","roleDisplay":"VerfasserIn","display":"Donnan, Geoffrey A","given":"Geoffrey A","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Gerloff, Christian","given":"Christian","family":"Gerloff","role":"aut"},{"role":"aut","family":"Nakahara","given":"Jin","roleDisplay":"VerfasserIn","display":"Nakahara, Jin"},{"role":"aut","family":"Toyoda","given":"Kazunori","roleDisplay":"VerfasserIn","display":"Toyoda, Kazunori"},{"roleDisplay":"VerfasserIn","given":"Götz","display":"Thomalla, Götz","family":"Thomalla","role":"aut"},{"display":"Koga, Masatoshi","roleDisplay":"VerfasserIn","given":"Masatoshi","family":"Koga","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy","subtitle":"post hoc analysis of the EOS individual participant data","title_sort":"Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy"}],"recId":"193225725X","id":{"eki":["193225725X"],"doi":["10.1177/17474930251322034"]},"name":{"displayForm":["Yuma Shiomi, Kaori Miwa, Märit Jensen, Manabu Inoue, Sohei Yoshimura, Naruhiko Kamogawa, Mayumi Fukuda-Doi, Henry Ma, Peter Ringleb, Ona Wu, Lee H Schwamm, Stephen M Davis, Geoffrey A Donnan, Christian Gerloff, Jin Nakahara, Kazunori Toyoda, Götz Thomalla and Masatoshi Koga, on behalf of Evaluation of Unknown Onset Stroke Thrombolysis trials (EOS) Investigators"]}} | ||
| SRT | |a SHIOMIYUMAEFFICACYAN7202 | ||